Immucell (ICCC) Share-based Compensation Growth (5y) (2015 - 2026)
Powered by 
Analysis
Immucell (ICCC) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.36 Bn | 40.16 Bn | 779.09 Mn |
| 2 | Zoetis | 29.60 Bn | 27.92 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.20 Bn | 10.67 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.40 Bn | 1.32 Bn | 134.40 Mn |
| 5 | Immucell | 90.37 Mn | 81.51 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.93 Mn | 65.85 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.42% |
| Dec 31, 2025 | 12.85% |
| Sep 30, 2025 | 23.49% |
| Jun 30, 2025 | 16.04% |
| Mar 31, 2025 | 12.40% |
| Dec 31, 2024 | -5.54% |
| Sep 30, 2024 | 14.85% |
| Jun 30, 2024 | 11.99% |
| Mar 31, 2024 | 11.19% |
| Dec 31, 2023 | 3.12% |
| Sep 30, 2023 | 35.91% |
| Jun 30, 2023 | 34.17% |
| Mar 31, 2023 | 42.91% |
| Sep 30, 2022 | 50.18% |
| Jun 30, 2022 | 16.72% |
| Mar 31, 2022 | 42.99% |
| Dec 31, 2021 | 19.09% |
| Sep 30, 2021 | 60.64% |
| Jun 30, 2021 | 61.98% |
| Mar 31, 2021 | 91.35% |